Impaired T-bet-pSTAT1α and perforin-mediated immune responses in the tumoral region of lung adenocarcinoma

British Journal of Cancer
Katerina AndreevSusetta Finotto

Abstract

In spite of modern therapies for non-small-cell lung cancer (NSCLC), prognosis for many patients is still poor and survival rates are low. Immunotherapy is the possibility to improve the lung immune response surrounding the tumour. However, this approach requires detailed understanding of the local immune-responses of NSCLC patients. We analysed samples from three different regions within the lungs of NSCLC patients, whereas we distinguished between patients suffering from adenocarcinoma and squamous cell carcinoma. Expression of type 1 T helper (Th1)/type 1 cytotoxic (Tc1) factors was assessed by quantitative real-time PCR, western blot analyses or immunohistochemistry. Cytotoxic cell activity of CD8(+) T cells was determined via co-culture with autologous tumour cells and apoptosis assay. We found decreased levels of the transcription factor T-box expressed in T cells (T-bet or Tbx21) and of the downstream activated IFN-γ-dependent pSTAT1α isoform in the lung tumour areas of patients with NSCLC as compared with tumour-free control regions. In these patients, reduced T-bet and pSTAT1α levels were found associated with increased immunosuppressive markers like cytotoxic T lymphocyte-associated protein 4, programmed cell death 1 ...Continue Reading

References

Aug 25, 1992·Proceedings of the National Academy of Sciences of the United States of America·C SchindlerJ E Darnell
Jan 1, 1995·Cancer·W D TravisS S Devesa
Jul 17, 1999·Brain Research. Developmental Brain Research·N KimuraT Taga
Oct 12, 2000·Proceedings of the National Academy of Sciences of the United States of America·E JägerA Knuth
Oct 2, 2001·CA: a Cancer Journal for Clinicians·R T GreenleeM Thun
Dec 26, 2001·Proceedings of the National Academy of Sciences of the United States of America·A A LighvaniJ J O'Shea
May 15, 2002·Nature Immunology·Maryam AfkarianKenneth M Murphy
Oct 3, 2002·Nature Reviews. Immunology·Joseph A Trapani, Mark J Smyth
Nov 18, 2004·Immunological Reviews·Sidney PestkaMark R Walter
Oct 6, 2005·Journal of Leukocyte Biology·Simone MocellinHoward A Young
Nov 8, 2005·Nature Immunology·Andrew M IntlekoferSteven L Reiner
Jan 5, 2008·Annual Review of Immunology·Mary E KeirArlene H Sharpe
Sep 26, 2008·The New England Journal of Medicine·Roy S HerbstScott M Lippman
Jan 14, 2009·The Journal of Experimental Medicine·Fernando Cruz-GuillotyAnjana Rao
Jan 29, 2010·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Hyo-Sung Jeon, Jin Jen
Nov 10, 2011·Cancer Research·William L ByrneGerald C O'Sullivan
Oct 12, 2013·Nature Reviews. Immunology·Vanja LazarevicGraham M Lord
Jul 1, 2014·European Journal of Immunology·Eva Van OvermeireJo A Van Ginderachter

❮ Previous
Next ❯

Citations

Jul 14, 2018·Cancer Biotherapy & Radiopharmaceuticals·Milad Sabzevary-GhahfarokhiMojtaba Shohan
Sep 18, 2018·Oncoimmunology·Katerina KachlerSusetta Finotto

❮ Previous
Next ❯

Methods Mentioned

BETA
FCS
PCR
electrophoresis
FACS
flow cytometry

Software Mentioned

Excel
Cell Quest Pro
CFX Manager

Related Concepts

Related Feeds

Carcinoma, Squamous Cell

Basal cell carcinoma is a form of malignant skin cancer found on the head and neck regions and has low rates of metastasis. Discover the latest research on basal cell carcinoma here.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis